8月28日，凯信远达(CASI)盘中上涨3.59%，截至21:54，报2.31美元/股，成交1.3万美元，总市值3578.81万美元。
财务数据显示，截至2025年03月31日，凯信远达收入总额624.0万美元，同比增长83.04%；归母净利润-1075.0万美元，同比减少12.83%。
大事提醒：
8月29日，凯信远达将披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。
资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。公司的总部位于美国马里兰州罗克韦尔市,在北京设有全资子公司,在无锡与当地政府设有合资子公司及研发中心。目前公司的产品及研发管线覆盖了多发性骨髓瘤、B细胞非霍奇金淋巴瘤、急性淋巴细胞白血病等多个疾病领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.